SS0331 is an inhaled medication that is given through a nebulizer, which is a device that turns liquid medicine into a mist that you breathe in. This medication is being tested to see if it can help reduce the amount of bacteria in the lungs of people who have long-term lung infections. The study is looking at whether this treatment is safe and whether it can help fight bacterial infections in the airways.

Chronic Airway Infections – Chronic airway infections are long-lasting infections that affect the breathing passages in the lungs. These infections occur when harmful bacteria settle in the airways and persist over time, causing ongoing inflammation and damage to the respiratory system. The condition leads to increased mucus production and difficulty clearing secretions from the lungs. Patients experience repeated episodes of coughing, excess sputum production, and breathing difficulties. The bacteria multiply in the airways and form communities that are difficult for the body’s immune system to eliminate. Over time, the persistent infection can cause progressive damage to the lung tissue and airways.

Cystic Fibrosis – Cystic fibrosis is an inherited disorder that affects the cells producing mucus, sweat, and digestive fluids. The condition causes these secretions to become thick and sticky instead of thin and slippery. The abnormal mucus blocks the airways in the lungs, trapping bacteria and leading to repeated infections. The thick secretions also obstruct the pancreas and prevent digestive enzymes from reaching the intestines. Patients experience persistent coughing, frequent lung infections, and difficulty breathing. The disease affects multiple organ systems and requires ongoing management throughout life.

Primary Ciliary Dyskinesia – Primary ciliary dyskinesia is an inherited condition that affects the tiny hair-like structures called cilia that line the airways. These cilia normally move in coordinated waves to clear mucus and trapped particles from the respiratory tract. In this condition, the cilia do not move properly or are completely immobile, preventing effective clearance of mucus. The buildup of mucus creates an environment where bacteria can grow, leading to chronic respiratory infections. Patients experience persistent wet cough, nasal congestion, and recurring ear and sinus infections. The impaired mucus clearance results in progressive lung damage over time.

Non-Cystic Fibrosis Bronchiectasis – Non-cystic fibrosis bronchiectasis is a condition where the airways in the lungs become permanently widened and damaged. The walls of the airways become thickened and scarred, losing their ability to clear mucus effectively. Mucus accumulates in the damaged airways, creating a breeding ground for bacterial infections. Patients experience a chronic productive cough with large amounts of sputum and repeated chest infections. The condition leads to a cycle where infection causes more damage, and the damage makes infections more likely. The airways gradually lose their function, resulting in progressive breathing difficulties.